Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 345
5
Diseases
91
Unique genes
0.208
Avg. similarity score
Carpal tunnel syndrome
Most-connected disease (3 links)
Disease
Searched: Carpal tunnel syndrome
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Carpal tunnel syndrome
Osteochondrodysplasias
Congenital cartilage disorder
Copper metabolism disorder
Rhizomelic dysplasia, ain-naz type
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Carpal tunnel syndrome | 3 | 3 | 63 |
| Osteochondrodysplasias | 3 | 3 | 33 |
| Congenital cartilage disorder | 2 | 2 | 30 |
| Copper metabolism disorder | 1 | 1 | 1 |
| Rhizomelic dysplasia, ain-naz type | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ADAMTSL2 | 3 / 5 | Carpal tunnel syndrome, Congenital cartilage disorder, Osteochondrodysplasias |
| COL10A1 | 3 / 5 | Carpal tunnel syndrome, Congenital cartilage disorder, Osteochondrodysplasias |
| COL11A1 | 3 / 5 | Carpal tunnel syndrome, Congenital cartilage disorder, Osteochondrodysplasias |
| COL11A2 | 3 / 5 | Carpal tunnel syndrome, Congenital cartilage disorder, Osteochondrodysplasias |
| COMP | 3 / 5 | Carpal tunnel syndrome, Congenital cartilage disorder, Osteochondrodysplasias |
| BCL2 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| BMPR1B | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| CCS | 2 / 5 | Carpal tunnel syndrome, Copper metabolism disorder |
| CHST3 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| COL2A1 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| COL9A1 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| COL9A2 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| COL9A3 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| DLL3 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| DYM | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| FLNA | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| FLNB | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| FLT1 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| GLB1 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| GNPNAT1 | 2 / 5 | Osteochondrodysplasias, Rhizomelic dysplasia, ain-naz type |
| HOXA11 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| HSPG2 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| KDR | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| LIFR | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| MATN3 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| PTH1R | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| SLC26A2 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| SOST | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| TGFB1 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| TRPS1 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| TRPV4 | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
| VEGFA | 2 / 5 | Congenital cartilage disorder, Osteochondrodysplasias |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| ECM proteoglycans | Reactome | 9 / 51 | 23.3× | 1.29e-10 | 1.85e-8 ✓ sig. |
| Focal adhesion | KEGG | 14 / 203 | 9.1× | 3.38e-10 | 4.42e-8 ✓ sig. |
| Non-integrin membrane-ECM interactions | Reactome | 6 / 24 | 33.0× | 1.93e-8 | 1.65e-6 ✓ sig. |
| Collagen chain trimerization | Reactome | 7 / 44 | 21.0× | 3.46e-8 | 2.74e-6 ✓ sig. |
| Collagen biosynthesis and modifying enzymes | Reactome | 8 / 67 | 15.8× | 3.60e-8 | 2.83e-6 ✓ sig. |
| Assembly of collagen fibrils and other multimeric structures | Reactome | 7 / 51 | 18.1× | 1.00e-7 | 7.03e-6 ✓ sig. |
| Integrin cell surface interactions | Reactome | 8 / 81 | 13.0× | 1.63e-7 | 1.07e-5 ✓ sig. |
| Cytoskeleton in muscle cells | KEGG | 12 / 232 | 6.8× | 1.67e-7 | 1.09e-5 ✓ sig. |
| ECM-receptor interaction | KEGG | 8 / 89 | 11.9× | 3.40e-7 | 2.04e-5 ✓ sig. |
| Signaling by PDGF | Reactome | 5 / 33 | 20.0× | 4.49e-6 | 1.86e-4 ✓ sig. |
| Molecules associated with elastic fibres | Reactome | 5 / 38 | 17.4× | 9.21e-6 | 3.33e-4 ✓ sig. |
| Protein digestion and absorption | KEGG | 7 / 103 | 9.0× | 1.25e-5 | 4.26e-4 ✓ sig. |
| NCAM1 interactions | Reactome | 4 / 21 | 25.1× | 1.67e-5 | 5.44e-4 ✓ sig. |
| VEGF binds to VEGFR leading to receptor dimerization | Reactome | 3 / 8 | 49.5× | 2.29e-5 | 7.07e-4 ✓ sig. |
| PI3K-Akt signaling pathway | KEGG | 11 / 361 | 4.0× | 8.54e-5 | 2.04e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| skeletal system development | GO:0001501 | 12 / 151 | 16.3× | 9.09e-12 | 3.37e-9 ✓ sig. |
| cartilage development | GO:0051216 | 7 / 89 | 16.2× | 2.56e-7 | 2.74e-5 ✓ sig. |
| chondrocyte differentiation | GO:0002062 | 6 / 61 | 20.2× | 5.05e-7 | 4.84e-5 ✓ sig. |
| collagen fibril organization | GO:0030199 | 6 / 65 | 19.0× | 7.40e-7 | 6.63e-5 ✓ sig. |
| chondrocyte development | GO:0002063 | 4 / 21 | 39.1× | 2.96e-6 | 2.03e-4 ✓ sig. |
| bone trabecula formation | GO:0060346 | 3 / 8 | 77.0× | 6.15e-6 | 3.66e-4 ✓ sig. |
| negative regulation of ossification | GO:0030279 | 4 / 27 | 30.4× | 8.48e-6 | 4.76e-4 ✓ sig. |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 3 / 9 | 68.5× | 9.19e-6 | 5.07e-4 ✓ sig. |
| ossification | GO:0001503 | 6 / 110 | 11.2× | 1.61e-5 | 7.84e-4 ✓ sig. |
| embryonic liver development | GO:1990402 | 2 / 2 | 205× | 2.35e-5 | 1.04e-3 ✓ sig. |
| regulation of chondrocyte differentiation | GO:0032330 | 3 / 12 | 51.3× | 2.38e-5 | 1.06e-3 ✓ sig. |
| positive regulation of vascular permeability | GO:0043117 | 3 / 12 | 51.3× | 2.38e-5 | 1.06e-3 ✓ sig. |
| surfactant homeostasis | GO:0043129 | 3 / 18 | 34.2× | 8.65e-5 | 2.82e-3 ✓ sig. |
| smooth muscle cell differentiation | GO:0051145 | 3 / 18 | 34.2× | 8.65e-5 | 2.82e-3 ✓ sig. |
| vascular endothelial growth factor signaling pathway | GO:0038084 | 3 / 19 | 32.4× | 1.02e-4 | 3.19e-3 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Congenital cartilage disorder | Osteochondrodysplasias | 0.882 | 30 | 3.54e-90 | 3.17e-88 ✓ sig. |
| Carpal tunnel syndrome | Congenital cartilage disorder | 0.056 | 5 | 1.28e-7 | 8.84e-7 ✓ sig. |
| Carpal tunnel syndrome | Osteochondrodysplasias | 0.054 | 5 | 2.12e-7 | 1.41e-6 ✓ sig. |
| Osteochondrodysplasias | Rhizomelic dysplasia, ain-naz type | 0.029 | 1 | 2.14e-3 | 3.04e-3 ✓ sig. |
| Carpal tunnel syndrome | Copper metabolism disorder | 0.016 | 1 | 4.09e-3 | 5.16e-3 ✓ sig. |